ARA-290 Protocol

Physician Services›Athletic Performance›ARA-290 Protocol
Peptide Therapy · Physician Services

ARA-290 Protocol

Compounded Injectable Peptide · Non-Erythropoietic · Physician Supervised
How this works: Clicking below takes you to TeleWellnessMD® where a licensed medical provider reviews your information. An initial consultation is required. Compounded medications are not FDA-approved as safe and effective for the treatment of any disease or condition.
25%
First Order Discount
Save 25% on your first order — automatically applied
when you use The Vitality Stack affiliate link.

About This Protocol

ARA-290 is a synthetic 11-amino acid peptide derived from the helix B region of erythropoietin. Unlike erythropoietin itself, ARA-290 is a non-erythropoietic compound — it does not affect red blood cell production. Instead it selectively activates the innate repair receptor (IRR), a tissue-protection pathway studied for nerve regeneration and anti-inflammatory signaling.

Available through TeleWellnessMD® licensed physicians in select states. The physician evaluates each patient individually and determines medical necessity.

Innate Repair Receptor (IRR)
ARA-290 selectively binds the innate repair receptor — a heterodimer distinct from the classical erythropoietin receptor. IRR activation triggers tissue-protective and anti-inflammatory signaling cascades without the erythropoietic effects of erythropoietin.
Neuroprotective Research
Research has examined ARA-290 in the context of small fiber neuropathy and nerve regeneration. Studies have looked at its potential effects on nerve fiber density and pain signaling in peripheral nerve tissue.
Anti-Inflammatory Signaling
IRR activation by ARA-290 has been studied for its effects on inflammatory cytokine production. Research has examined reductions in TNF-alpha and IL-6 in preclinical models following ARA-290 administration.
Non-Erythropoietic
The separation of tissue-protective effects from red blood cell stimulation is the key pharmacological feature of ARA-290. This allows potential use without the cardiovascular risks associated with erythropoietin's hematopoietic effects.

Available Options

Select the option appropriate for your protocol. If you are new, begin with the starting dose. Your physician will guide progression based on individual response and medical evaluation.

Standard Vial
ARA-290
8mg/mL · 7.5mL Vial
$799.95
31g syringes ×40 · Alcohol wipes ×40 · Mix kit ×1
Begin Evaluation
Physician approval required

What to Expect

After selecting an option above you will be directed to the TeleWellnessMD® platform. A licensed medical provider will review your health information and determine whether this protocol is appropriate. An initial consultation is required. Prescription availability varies by state.

Results and side effects vary from patient to patient.

Not Sure Where to Start?

Speak with a Licensed Provider

Start with a free physician assessment. A TeleWellnessMD® provider will evaluate your situation and recommend the appropriate protocol.

Start Free Assessment →
25% off your first order · Automatically applied · No obligation · Physician determines medical necessity

Compounded medications are not FDA-approved as safe and effective for the treatment of any disease or condition. The FDA does not review compounded formulations for safety, effectiveness, or quality. Compounded medications are prepared by a state-regulated licensed pharmacy in accordance with a prescriber's order. Results and side effects may vary from patient to patient. The Vitality Stack is an advertising affiliate of TeleWellnessMD® and may earn a commission if you complete a purchase. This content is for educational and advertising purposes only and does not constitute medical advice. Consult a licensed physician before starting any medication protocol.